UCB
Emmanuel leads the worldwide development and commercialization of innovative patientoriented solutions that create value for people suffering from autoimmune disorders, such as psoriatic arthritis, psoriasis, axial spondyloarthritis, lupus, rheumatoid arthritis, Crohn’s disease as well as osteoporosis. He is also in charge of UCB's corporate activities in the US.
This person is not in any offices
UCB
45 followers
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology.